NASDAQ has developped Rising wedge on 1 day time frame
38
US Tech 100 CFD (NASDAQ) – Weekly Chart Analysis (Feb 25, 2025) 1. Market Structure & Trend Analysis The chart shows a clear uptrend but with a recent rising wedge breakdown, which is typically a bearish reversal pattern. A strong rejection from all-time highs (~22,000) suggests that sellers are stepping in. Key downside target: The chart highlights a possible 15-16% drop towards the 18,000-19,000 demand zone, marked in purple. This area aligns with previous consolidation and strong support from mid-2023. 2. RSI & Momentum Analysis The RSI (Relative Strength Index) is at 54, showing neutral momentum but trending downward, indicating potential weakening of bullish strength. If RSI drops below 50, it could confirm further downside pressure. 3. Key Levels to Watch Resistance: 22,000 - 22,200 (Recent highs and breakout failure) 21,700 - 21,800 (Minor resistance before further downside) Support: 19,000 - 18,500 (First major support level, previous demand zone) 17,500 - 18,000 (Stronger structural support if decline accelerates) 4. Potential Trade Scenarios 📉 Bearish Scenario (Primary Setup)
If price fails to reclaim 21,700-22,000, the breakdown is confirmed, leading to a short opportunity with targets at 19,000 - 18,500. Stop-loss: Above 22,000 (Invalidation of breakdown). 📈 Bullish Rebound (Less Likely)
If the index finds support around 19,000 and shows strong buying reaction, it could trigger a long opportunity back towards 21,500 - 22,000. Confirmation: RSI bouncing from oversold levels & strong reversal candle. 5. Conclusion & Strategy Bearish bias in the short term due to wedge breakdown. Watching 19,000 - 18,500 for potential reversal or continuation lower. Short-term traders: Look for confirmation before entering trades.
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.